Role of oral erythromycin for feed intolerance in neonates - A randomized controlled trial
Journal Title: Indian Journal of Child Health - Year 2018, Vol 5, Issue 6
Abstract
Objective: The objective of this study was to compare the effect of high and low dose of erythromycin with placebo and to determine the efficacy and safety of oral erythromycin for feed intolerance in neonates admitted to the neonatal intensive care unit. Methodology: The study was a double-blind, randomized, and placebo-controlled trial. Term and preterm babies having feed intolerance were included in the study, and babies with congenital malformations, necrotizing enterocolitis, and sepsis were excluded from the study. After parental consent, the subjects were randomized into Groups 1, 2, or 3 to receive low-dose (3 mg/kg/dose) or high-dose (10 mg/kg/dose) oral erythromycin estolate or the placebo (equal volume of 5% dextrose). Feeding of all the study neonates was managed as per the unit protocol and babies were monitored for the complications. The primary outcome was the time to reach full feeds of 150 ml/kg/day, without significant gastric residuals. Results: Of 58 eligible babies, 84.5% were preterm babies. The median time for reaching full feeds with placebo was 6 days with interquartile range 3–4 days, for high dose was 4 (3–7) days and for low dose 6 (4.3–7) days (p=0.47). The total duration of erythromycin for placebo, high-dose, and low-dose group was median days 11 (7–14), 9 (7–13), and 9 (7–14), respectively, with p=0.86. There was no difference in the incidence of raised liver enzymes, vomiting, sepsis, and need for intravenous fluids, total parenteral nutrition, and duration of hospital stay between the groups. None of the babies had adverse events such as fatal arrhythmias and pyloric stenosis. Conclusion: There was no significant difference in the time to reach full feeds after erythromycin and the duration of study medication between the high‑dose and low-dose erythromycin with the placebo group. No adverse effects were seen in any of the groups.
Authors and Affiliations
Chandrakala Bada Shekharappa, Swarnarekha Bhat, Ashok Chandrasekaran
Keywords
Related Articles
- EP ID EP465531
- DOI -
- Views 47
- Downloads 0
Neonatal diabetes mellitus due to a rare mutation in KCNJ11 gene
Neonatal diabetes is a heterogeneous group of rare monogenic disorders with an incidence of about 1 in 100,000 live births presenting with in the first 6 months of life with polyuria, dehydration, and ketoacidosis. We, h...
Effectiveness of video-assisted teaching program on dental hygiene among children
Introduction: Worldwide, dental problems affect children’s health, causing millions of school hours to be lost each year. An effective community prevention program as a planned procedure prevents the onset of a disease a...
Clinical profile of children with diabetic ketoacidosis and related cerebral edema in a tertiary care hospital from Southern Kerala
Objective: To study the clinical profile of children admitted with diabetic ketoacidosis (DKA) in the pediatric intensive care unit (PICU) of a tertiary care teaching hospital. To assess the risk factors for the developm...
Second malignant neoplasm in a treated Ewing sarcoma patient: A case report
Ewing sarcoma (ES) is an aggressive tumor commonly seen in children and young adults. Late effects of ES therapy include the second cancers, a tragic outcome for survivors of such young age. We report a case of a 3-year-...
The factors affecting resolution of acidosis in children with diabetic ketoacidosis - A retrospective study from a tertiary care center in India
Background: Diabetic ketoacidosis (DKA) is characterized by a spectrum of clinical manifestations due to deficiency of insulin which results in hyperglycemia, ketonemia with ketonuria, and metabolic acidosis. Administrat...